Changing Services, Changing Oncology Pharmacy COVID-19 Position Statement

During the COVID-19 pandemic, oncology pharmacy services have had to adapt quickly and innovatively to continue to provide care to cancer patients. This document outlines both the clinical and operational responses implemented by BOPA members during the initial phase of COVID-19.

For clinical services we summarise different examples of responses , the key role oncology pharmacy services play in this response and recommendations for continued oncology pharmacy involvement in the future.
For operational services we identify the benefits, opportunities, risks and challenges of the responses and further considerations for reviewing these responses.

The document also highlights some of the next steps oncology pharmacy services and the wider oncology service could take in planning for the future phase of the COVID-19 pandemic.

We hope BOPA members find this document useful as it shows how we in oncology pharmacy have a pivotal role in providing cancer care and that whatever the challenges of continuing to provide care in a post COVID-19 world, so long as we plan for the risks, take opportunities, prepare to adapt and share our learning as a community, we will be able to meet them.

To access the document you must be a free or paid member of BOPA.
https://www.bopa.org.uk/resources/changing-services-changing-oncology-pharmacy-covid-19-position-statement/ 

Latest News

By BOPA Research Committee on 25th April 2024

Survey: Pharmacogenomic Panel Testing in Cancer: UK Oncology Professionals

Please consider completing our BOPA member survey on the use of pharmacogenomic panel testing in people with solid tumours. Survey information I’m a pharmacist and pre-doctoral research fellow researching the…

Read article
By BOPA Research committee on 25th April 2024

NIHR Associate Principal Investigator (PI) Scheme is continuing to host Research Learning Lectures

The NIHR Associate Principal Investigator (PI) Scheme is continuing to host the Research Learning Lectures; a series of lectures for anyone in Health and Social Care interested in learning more about research.…

Read article
By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article